Sinco Pharmaceuticals Holdings Limited
HKEX:6833.HK
0.184 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 437.922 | 329.144 | 326.052 | 143.765 | 219.755 | 80.33 | 22.71 | 102.05 | 38.138 | 58.28 | 27.851 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 1.99 | 16.154 | 1.818 | 113.009 | 1.158 | 0 | 0 |
| Cash and Short Term Investments
| 437.922 | 329.144 | 326.052 | 143.765 | 221.745 | 96.484 | 24.528 | 215.205 | 39.296 | 58.28 | 27.851 |
| Net Receivables
| 540.505 | 351.268 | 213.601 | 578.687 | 30.71 | 26.177 | 37.106 | 19.868 | 77.186 | 36.916 | 13.934 |
| Inventory
| 108.026 | 89.584 | 62.762 | 242.561 | 267.109 | 247.247 | 294.321 | 158.725 | 46.563 | 100.676 | 149.085 |
| Other Current Assets
| 346.83 | 247.41 | 366.562 | 40.714 | 106.339 | 16.177 | 194.678 | 96.419 | 56.712 | 92.22 | 82.323 |
| Total Current Assets
| 1,433.283 | 1,017.406 | 968.977 | 1,005.727 | 625.903 | 386.085 | 550.633 | 490.071 | 219.757 | 288.092 | 273.193 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 354.208 | 315.839 | 256.261 | 238.183 | 198.034 | 181.809 | 191.767 | 103.712 | 96.922 | 100.094 | 58.844 |
| Goodwill
| 66.536 | 66.536 | 0 | 0 | 0 | 0 | 23.701 | 58.632 | 35.526 | 0 | 0 |
| Intangible Assets
| 27.109 | 15.001 | 0 | 0.022 | 0.045 | 0.113 | 0.223 | 32.454 | 40.378 | 0 | 0 |
| Goodwill and Intangible Assets
| 93.645 | 81.537 | 0 | 0.022 | 0.045 | 0.113 | 23.924 | 91.086 | 75.904 | 0 | 0 |
| Long Term Investments
| -3.403 | 394.375 | 0 | 237.559 | 197.358 | 180.622 | 206.532 | 0 | 0 | 0 | 0 |
| Tax Assets
| 3.403 | 3.001 | 0.86 | 0.646 | 0.721 | 1.3 | 9.159 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 9.542 | -397.376 | -0.86 | -238.205 | -198.079 | -181.922 | -215.691 | -194.798 | -172.826 | -100.094 | 44.808 |
| Total Non-Current Assets
| 457.395 | 397.376 | 256.261 | 238.205 | 198.079 | 181.922 | 215.691 | 194.798 | 172.826 | 100.094 | 103.652 |
| Total Assets
| 1,890.678 | 1,424.333 | 1,232.766 | 1,252.053 | 832.344 | 611.762 | 819.219 | 787.727 | 465.01 | 441.214 | 376.845 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 866.585 | 407.988 | 422.933 | 700.32 | 300.466 | 106.901 | 22.522 | 45.832 | 62.793 | 18.637 | 7.546 |
| Short Term Debt
| 244.69 | 183.804 | 208.704 | 78.722 | 188.506 | 145 | 409.671 | 165 | 81.915 | 91.788 | 62.915 |
| Tax Payables
| 34.368 | 9.217 | 13.671 | 23.799 | 12.147 | 8.66 | 2.879 | 12.221 | 8.909 | 5.58 | 0 |
| Deferred Revenue
| -3.833 | -183.804 | -208.704 | -78.722 | -188.506 | -145 | -409.671 | -165 | -81.915 | -91.788 | 0 |
| Other Current Liabilities
| 124.595 | 382.597 | 302.703 | 290.473 | 355.325 | 482.138 | 523.967 | 284.62 | 208.663 | 299.092 | 258.028 |
| Total Current Liabilities
| 1,232.037 | 790.585 | 725.636 | 990.793 | 655.791 | 589.039 | 546.489 | 330.452 | 271.456 | 317.729 | 328.489 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 6.711 | 0.922 | 132.244 | 3.042 | 0.154 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| -1.8 | -1.328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.8 | 2.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 23.878 | -0.922 | -132.244 | -3.042 | 195.962 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 30.589 | 0.922 | 132.244 | 3.042 | 196.116 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 1,262.626 | 820.521 | 857.88 | 1,087.624 | 786.052 | 589.039 | 546.489 | 330.452 | 271.456 | 317.729 | 328.489 |
| Equity: | |||||||||||
| Preferred Stock
| 29.727 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.164 | 0.164 | 0.151 | 0.136 | 0.136 | 0.136 | 0.13 | 0.13 | 0.095 | 0 | 0 |
| Retained Earnings
| 68.686 | 74.173 | 0.478 | -135.082 | -253.219 | -276.771 | 4.007 | 189.903 | 170.536 | 100.922 | 36.555 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 4.233 | 6.92 | 6.92 | 6.901 | 6.361 | 5.009 | 4.014 | 0.042 | 0.042 |
| Other Total Stockholders Equity
| 529.475 | 529.475 | 370.024 | 293.363 | 293.363 | 293.363 | 263.137 | 263.137 | 18.783 | 4.25 | 4.25 |
| Total Shareholders Equity
| 628.052 | 603.812 | 374.886 | 165.337 | 47.2 | 23.629 | 273.635 | 458.179 | 193.428 | 105.214 | 40.847 |
| Total Equity
| 628.052 | 603.812 | 374.886 | 164.429 | 46.292 | 22.723 | 272.73 | 457.275 | 193.554 | 123.485 | 48.356 |
| Total Liabilities & Shareholders Equity
| 1,890.678 | 1,424.333 | 1,232.766 | 1,252.053 | 764.125 | 611.762 | 819.219 | 787.727 | 464.216 | 441.214 | 376.845 |